Αποτελέσματα Αναζήτησης
1 Απρ 2022 · Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients.
- 2022 Aha/Acc/Hfsa Guideline for The
The webpage provides access to AHA/ASA journals on...
- 2022 Aha/Acc/Hfsa Guideline for The
25 Αυγ 2021 · 25 Aug 2021. The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence. Fortunately, we now have a wealth of clinical trials to help us select the best management to improve the outcomes for people with HF; for many, it is now both preventable and treatable.
30 Ιαν 2023 · In people with suspected heart failure, doctors may order the following blood tests: Basic metabolic panel (BMP) A BMP is a comprehensive set of tests that can provide insights into a...
15 Ιουν 2012 · Initial Clinical Evaluation. Although no single item on clinical history, sign, or symptom has been proven to be diagnostic, many are helpful in assessing the probability of heart failure.
There is no single diagnostic test for heart failure, and the diagnosis relies on clinical judgement based on a combination of history, physical examination and appropriate investigations. Biomarkers are substances measurable in the blood stream which can be used to diagnose and monitor disease.
18 Ιαν 2024 · If a patient has a positive test for antinuclear antibodies (ANA), their health care provider, depending on the patient's symptoms or findings on physical examination, may order additional tests to identify specific types of autoantibodies.
Blood tests to assess the risk of heart failure include lipoprotein (or lipid) panels which evaluate fats in the blood, including cholesterol. Abnormal levels can be a sign of the presence or risk of heart disease.
